| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |